Mostrar el registro sencillo del ítem

dc.contributor.author
Zamberlin, Nina  
dc.contributor.author
Romero, Mariana  
dc.contributor.author
Ramos, Silvina  
dc.date.available
2023-06-02T14:01:40Z  
dc.date.issued
2012-12  
dc.identifier.citation
Zamberlin, Nina; Romero, Mariana; Ramos, Silvina; Latin American women’s experiences with medical abortion in settings where abortion is legally restricted; BioMed Central; Reproductive Health; 9; 1; 12-2012; 1-11  
dc.identifier.issn
1742-4755  
dc.identifier.uri
http://hdl.handle.net/11336/199360  
dc.description.abstract
Abortion is legally restricted in most of Latin America where 95% of the 4.4 million abortions performed annually are unsafe. Medical abortion (MA) refers to the use of a drug or a combination of drugs to terminate pregnancy. Mifepristone followed by misoprostol is the most effective and recommended regime. In settings where mifepristone is not available, misoprostol alone is used.Medical abortion has radically changed abortion practices worldwide, and particularly in legally restricted contexts. In Latin America women have been using misoprostol for self-induced home abortions for over two decades.This article summarizes the findings of a literature review on women's experiences with medical abortion in Latin American countries where voluntary abortion is illegal.Women's personal experiences with medical abortion are diverse and vary according to context, age, reproductive history, social and educational level, knowledge about medical abortion, and the physical, emotional, and social circumstances linked to the pregnancy. But most importantly, experiences are determined by whether or not women have the chance to access: 1) a medically supervised abortion in a clandestine clinic or 2) complete and accurate information on medical abortion. Other key factors are access to economic resources and emotional support.Women value the safety and effectiveness of MA as well as the privacy that it allows and the possibility of having their partner, a friend or a person of their choice nearby during the process. Women perceive MA as less painful, easier, safer, more practical, less expensive, more natural and less traumatic than other abortion methods. The fact that it is self-induced and that it avoids surgery are also pointed out as advantages. Main disadvantages identified by women are that MA is painful and takes time to complete. Other negatively evaluated aspects have to do with side effects, prolonged bleeding, the possibility that it might not be effective, and the fact that some women eventually need to seek medical care at a hospital where they might be sanctioned for having an abortion and even reported to the police.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
BioMed Central  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
medical abortion  
dc.subject
misoprostol  
dc.subject
Latin America  
dc.subject.classification
Ciencias Sociales Interdisciplinarias  
dc.subject.classification
Otras Ciencias Sociales  
dc.subject.classification
CIENCIAS SOCIALES  
dc.title
Latin American women’s experiences with medical abortion in settings where abortion is legally restricted  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2023-05-31T15:08:38Z  
dc.journal.volume
9  
dc.journal.number
1  
dc.journal.pagination
1-11  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Zamberlin, Nina. Centro de Estudios de Estado y Sociedad; Argentina  
dc.description.fil
Fil: Romero, Mariana. Centro de Estudios de Estado y Sociedad; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Ramos, Silvina. Centro de Estudios de Estado y Sociedad; Argentina  
dc.journal.title
Reproductive Health  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://reproductive-health-journal.biomedcentral.com/articles/10.1186/1742-4755-9-34  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/1742-4755-9-34